Leukemia: A Review of Data from the ASH 2021 Meeting - Episode 2
Shared insight on updates in the chronic myeloid leukemia treatment landscape following the ASH 2021 annual meeting.
Data from the following clinical trials are discussed:
Supported in part by Takeda Oncology. Content developed independently by Onclive®.